Osimertinib for Secondary T790m-Mutation–Positive Squamous Cell Carcinoma Transformation After Afatinib Failure

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.07.100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Squamous Cell Carcinoma “Transformation” Concurrent With Secondary T790M Mutation in Resistant EGFR -Mutated Adenocarcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

PLoS ONE
Multidisciplinary
2019English

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.13-23 Osimertinib Treatment Result of Plasma T790M Positive in Different Clinical Failure Modes After First-Line EGFR TKI for EGFR Mutant NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2017English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

Cancers
Cancer ResearchOncology
2019English

P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas V2 After Acquired Resistance to Afatinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Osimertinib Plus Durvalumab Versus Osimertinib Monotherapy in EGFR T790m-Positive NSCLC Following Previous EGFR-TKI Therapy: CAURAL Brief Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy